Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SYK | P43405 | 3/20 | 0.41 |
| ▸ | ABCG2 | Q9UNQ0 | 2/20 | 0.41 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.41 |
| ▸ | CTSC | P53634 | 6/20 | 0.40 |
| ▸ | IDH2 | P48735 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | AR | P10275 | 1/20 | 0.38 |
| ▸ | TLR7 | Q9NYK1 | 1/20 | 0.38 |
| ▸ | EGFR | P00533 | 2/20 | 0.38 |
| ▸ | BRD4 | O60885 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24754876 | 0.86 | AURKA (0.46) | SYKMAPTTLR7EGFR | |
| SCHEMBL30177167 | 0.72 | ABCG2 (0.46) | SYKABCG2GRM4LMNAMAPT | |
| SCHEMBL24754871 | 0.71 | MAPT (0.49) | SYKABCG2GRM4CTSCIDH2 | |
| SCHEMBL12368474 | 0.69 | TDP1 (0.50) | ABCG2GRM4LMNAEGFR | |
| SCHEMBL28468375 | 0.67 | ABCG2 (0.48) | ABCG2GRM4CTSCIDH2LMNA | |
| SCHEMBL14243705 | 0.67 | KCNH3 (0.50) | ABCG2CTSCIDH2LMNAMAPT | |
| SCHEMBL12279158 | 0.66 | BRD4 (0.56) | SYKABCG2GRM4CTSCEGFR | |
| SCHEMBL24754877 | 0.66 | TLR7 (0.38) | IDH2TLR7 | |
| SCHEMBL653263 | 0.66 | SYK (0.53) | SYKABCG2GRM4CTSCBRD4 | |
| SCHEMBL21625856 | 0.66 | KIF11 (0.54) | ABCG2GRM4IDH2MAPTAR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12610730-B2 | Metal complex and light emitting device | CITY UNIVERSITY OF HONG KONG (HK) | 2026-04-21 | — | — | US | disclosed |
| US-20230006152-A1 | METAL COMPLEX AND LIGHT EMITTING DEVICE | CITY UNIVERSITY OF HONG KONG (HK) | 2023-01-05 | — | — | US | disclosed |
| US-20220402955-A1 | METAL COMPLEX AND LIGHT EMITTING DEVICE | CITY UNIVERSITY OF HONG KONG (HK) | 2022-12-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230006152-A1 | METAL COMPLEX AND LIGHT EMITTING DEVICE | OCIAD1, OCIAD2, OPRD1 | SYK 3888/4885ABCG2 2953/4885GRM4 2352/4885 |
| US-12610730-B2 | Metal complex and light emitting device | OPRD1, OCIAD2, ORC3 | SYK 2503/4885ABCG2 2555/4885GRM4 999/4885 |
| US-20220402955-A1 | METAL COMPLEX AND LIGHT EMITTING DEVICE | OCIAD1, OCIAD2, OSTC | SYK 3587/4885ABCG2 3580/4885GRM4 2407/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.